HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Louk J M J Vanderschuren Selected Research

Weight Gain

11/2013Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability.
4/2012Olanzapine and sibutramine have opposing effects on the motivation for palatable food.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Louk J M J Vanderschuren Research Topics

Disease

7Substance-Related Disorders (Drug Abuse)
01/2018 - 12/2005
3Cocaine-Related Disorders (Cocaine Addiction)
11/2021 - 06/2012
3Alcoholism (Alcohol Abuse)
12/2015 - 09/2009
3Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2015 - 04/2008
3Obesity
01/2012 - 04/2008
3Mental Disorders (Mental Disorder)
04/2011 - 04/2007
2Opioid-Related Disorders (Opiate Addiction)
11/2021 - 06/2012
2Parkinson Disease (Parkinson's Disease)
01/2018 - 01/2012
2AIDS-Related Complex (ARC)
03/2017 - 01/2016
2Brain Diseases (Brain Disorder)
12/2015 - 01/2012
2Weight Gain
11/2013 - 04/2012
1Neuroblastoma
01/2020
1Leukemia
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Mania (Manias)
01/2018
1Antisocial Personality Disorder (Antisocial Personality)
04/2014
1Gambling (Pathological Gambling)
02/2013
1Tobacco Use Disorder (Nicotine Dependence)
06/2012
1Body Weight (Weight, Body)
04/2012
1Feeding and Eating Disorders (Eating Disorder)
01/2012
1Bulimia (Binge Eating)
01/2012
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
01/2012
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2012
1Cognitive Dysfunction
10/2011
1Hyperphagia (Overeating)
06/2011
1Personality Disorders (Personality Disorder)
04/2011
1Autistic Disorder (Autism)
04/2011
1Schizophrenia (Dementia Praecox)
04/2011
1Hypersensitivity (Allergy)
01/2010
1Marijuana Use
04/2008
1Drug Hypersensitivity (Drug Allergy)
12/2002

Drug/Important Bio-Agent (IBA)

9Pharmaceutical PreparationsIBA
01/2018 - 12/2005
6Dopamine (Intropin)FDA LinkGeneric
01/2018 - 04/2007
5Norepinephrine (Noradrenaline)FDA LinkGeneric
02/2013 - 04/2008
4Cocaine (Cocaine HCl)IBA
11/2021 - 10/2011
4Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2015 - 04/2008
3Methylphenidate (Ritalin)FDA LinkGeneric
01/2015 - 04/2008
3Amphetamine (Amfetamine)FDA LinkGeneric
02/2013 - 12/2002
2NicotineFDA Link
11/2021 - 06/2012
2Serotonin (5 Hydroxytryptamine)IBA
02/2013 - 01/2012
2Opioid Analgesics (Opioids)IBA
06/2012 - 04/2008
1Cytostatic AgentsIBA
01/2020
1Vincristine (Oncovin)FDA LinkGeneric
01/2020
1Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2017
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
01/2016
1RimonabantIBA
11/2013
1CitalopramFDA LinkGeneric
02/2013
1Dopamine AntagonistsIBA
06/2012
1ecopipamIBA
06/2012
1Antipsychotic Agents (Antipsychotics)IBA
04/2012
1Olanzapine (Zyprexa)FDA Link
04/2012
1Sucrose (Saccharose)IBA
04/2012
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
04/2012
1Reducing AgentsIBA
04/2012
1sibutramine (Meridia)FDA Link
04/2012
1Quinine (Quinson)FDA Link
01/2012
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2012
1LeptinIBA
06/2011
1MelanocortinsIBA
06/2011
1Insulin (Novolin)FDA Link
06/2011
1Opioid Receptors (Opioid Receptor)IBA
04/2011
14,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA
04/2011
1Ethanol (Ethyl Alcohol)IBA
09/2009
1Therapeutic UsesIBA
11/2008
1Adrenergic Receptors (Adrenergic Receptor)IBA
11/2008
1EndocannabinoidsIBA
04/2008

Therapy/Procedure

3Therapeutics
11/2021 - 06/2012
2Self Administration (Administration, Self)
03/2017 - 01/2012
1Deep Brain Stimulation
01/2012